malondialdehyde has been researched along with Acquired Metabolic Diseases, Brain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amaral, AU; de Souza, DO; Goodman, SI; Leipnitz, G; Rodrigues, MD; Seminotti, B; Wajner, M; Woontner, M | 1 |
| Arnal, E; Barcia, J; Bosch-Morell, F; Miranda, M; Romero, FJ | 1 |
2 other study(ies) available for malondialdehyde and Acquired Metabolic Diseases, Brain
| Article | Year |
|---|---|
Experimental evidence that overexpression of NR2B glutamate receptor subunit is associated with brain vacuolation in adult glutaryl-CoA dehydrogenase deficient mice: A potential role for glutamatergic-induced excitotoxicity in GA I neuropathology.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Brain Diseases, Metabolic; Brain Injuries; Catalase; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Fluoresceins; Gene Expression Regulation; Glucosephosphate Dehydrogenase; Glutaryl-CoA Dehydrogenase; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Malondialdehyde; Mice; Mice, Transgenic; NAD; Receptors, N-Methyl-D-Aspartate; Sulfhydryl Compounds; Superoxide Dismutase | 2015 |
Lutein and docosahexaenoic acid prevent cortex lipid peroxidation in streptozotocin-induced diabetic rat cerebral cortex.
Topics: Aldehydes; Animals; Antigens, Nuclear; Antioxidants; Biomarkers; Brain Diseases, Metabolic; Cerebral Cortex; Diabetes Complications; Diabetes Mellitus, Experimental; Disease Models, Animal; Docosahexaenoic Acids; Drug Therapy, Combination; Fluorescent Antibody Technique; Glucose; Glutathione; Glutathione Peroxidase; Hyperglycemia; Insulin; Lipid Peroxidation; Lutein; Male; Malondialdehyde; Nerve Tissue Proteins; Oxidative Stress; Rats; Rats, Wistar; Treatment Outcome | 2010 |